Chugai Pink Sheet Today

CHGCF
 Stock
  

USD 22.86  0.00  0.00%   

Market Performance
0 of 100
Odds Of Distress
Less than 10
Chugai Pharmaceutical is trading at 22.86 as of the 9th of December 2022, a No Change since the beginning of the trading day. The stock's lowest day price was 22.86. Chugai Pharmaceutical has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Chugai Pharmaceutical Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 19th of December 2020 and ending today, the 9th of December 2022. Click here to learn more.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. The company has 1.64 B outstanding shares of which 0 shares are currently shorted by private and institutional investors with about 0.0 days to cover all short positions. More on Chugai Pharmaceutical Co

Moving together with Chugai Pharmaceutical

+0.81PHVSPharvaris BV TrendingPairCorr

Moving against Chugai Pharmaceutical

-0.74PFEPfizer Inc Sell-off TrendPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Chugai Pharmaceutical Pink Sheet Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Chugai Pharmaceutical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Chugai Pharmaceutical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chugai Pharmaceutical generated a negative expected return over the last 90 days
About 60.0% of the company shares are held by company insiders
Chairman and CEOOsamu Nagayama
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Chugai Pharmaceutical's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Chugai Pharmaceutical Co [CHGCF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 43.43 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chugai Pharmaceutical's market, we take the total number of its shares issued and multiply it by Chugai Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Chugai Pharmaceutical classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.64 B outstanding shares of which 0 shares are currently shorted by private and institutional investors with about 0.0 days to cover all short positions. Chugai Pharmaceutical Co has accumulated about 545.3 B in cash with 279.63 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 331.48, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Chugai Pharmaceutical Probability Of Bankruptcy
Ownership
Chugai Pharmaceutical holds a total of one billion six hundred fourty-four million three hundred twenty thousand outstanding shares. Chugai Pharmaceutical Co retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Chugai Ownership Details

Chugai Stock Price Odds Analysis

What are Chugai Pharmaceutical's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Chugai Pharmaceutical jumping above the current price in 90 days from now is about 90.6%. The Chugai Pharmaceutical Co probability density function shows the probability of Chugai Pharmaceutical pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Chugai Pharmaceutical has a beta of 0.1474 suggesting as returns on the market go up, Chugai Pharmaceutical average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Chugai Pharmaceutical Co will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Chugai Pharmaceutical is significantly underperforming NYSE Composite.
  Odds Below 22.86HorizonTargetOdds Above 22.86
9.33%90 days
 22.86 
90.60%
Based on a normal probability distribution, the odds of Chugai Pharmaceutical to move above the current price in 90 days from now is about 90.6 (This Chugai Pharmaceutical Co probability density function shows the probability of Chugai Pink Sheet to fall within a particular range of prices over 90 days) .

Chugai Pharmaceutical Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Chugai Pharmaceutical market risk premium is the additional return an investor will receive from holding Chugai Pharmaceutical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Chugai Pharmaceutical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Chugai Pharmaceutical's alpha and beta are two of the key measurements used to evaluate Chugai Pharmaceutical's performance over the market, the standard measures of volatility play an important role as well.

Chugai Stock Against Markets

Picking the right benchmark for Chugai Pharmaceutical pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Chugai Pharmaceutical pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Chugai Pharmaceutical is critical whether you are bullish or bearish towards Chugai Pharmaceutical Co at a given time.
The entity Chugai Pharmaceutical Co with a symbol CHGCF was recently relisted or delisted. You can potentially use Chugai Pharmaceutical Co with a symbol CHGCF. Please make sure the ticker renaming or change in the classification of Chugai Pharmaceutical Co is not a temporary action by the exchange.

Chugai Pharmaceutical Corporate Directors

Chugai Pharmaceutical corporate directors refer to members of a Chugai Pharmaceutical board of directors. The board of directors generally takes responsibility for the Chugai Pharmaceutical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Chugai Pharmaceutical's board members must vote for the resolution. The Chugai Pharmaceutical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Masayuki Oku - Independent DirectorProfile
Franz Humer - Independent DirectorProfile
Sophie KornowskiBonnet - Independent DirectorProfile
Yasuo Ikeda - Independent DirectorProfile

Invested in Chugai Pharmaceutical Co?

The danger of trading Chugai Pharmaceutical Co is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Chugai Pharmaceutical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Chugai Pharmaceutical. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Chugai Pharmaceutical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Chugai Pharmaceutical information on this page should be used as a complementary analysis to other Chugai Pharmaceutical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Chugai Pink Sheet analysis

When running Chugai Pharmaceutical price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Please note, there is a significant difference between Chugai Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine Chugai Pharmaceutical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chugai Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.